Pulmonary Vascular Research Institute (PVRI) 2025 Rio: Embracing Heterogeneity

Pulmonary Vascular Research Institute (PVRI) 2025 Rio: Embracing Heterogeneity is organized by Pulmonary Vascular Research Institute (PVRI) and will be held from Jan 29 - Feb 01, 2025 will be hosted in the vibrant and captivating city of Rio de Janeiro at the Windsor Convention & Expo Centre, R. Martinho de Mesquita, 129 - Barra da Tijuca, Rio de Janeiro - RJ, 20031-204, Brazil.

Description:
Esteemed experts, healthcare professionals, and researchers from around the globe will converge in this iconic city to share groundbreaking insights, foster collaborations, and advance our collective mission towards conquering Pulmonary Vascular Diseases (PVDs). 

Submit your abstract:
All accepted abstracts will be published in our journal, Pulmonary Circulation, and may appear on our website. There is no fee for abstract submission, but the submitting author must have an active PVRI membership to submit. The best abstracts in the following areas will be selected for oral presentations in our main programme, so please indicate if your submission is relevant to one of these areas when you submit: 

• Establishing the framework for the classification & diagnosis of PH worldwide 
• Risk stratification & treatment in the new era of PH therapeutics 
• Vascular heterogeneity in chronic lung disease Heterogeneity in PH associated with heart disease 
• The individual exposome & it’s contribution to PH heterogeneity 
• Quantifying therapeutic responses 
• Leveraging disease heterogeneity in clinical trial design 
• None of the above 

 The best abstracts will also be considered for travel awards based on available funding. For more detail, please read our abstract guidance, terms & conditions on PVRI website.

Submissions close 7 October 2024. 

Programme
Pre-meetings: 29 January

• 08:00-16:00: Innovative Drug Development Initiative (IDDI) Meeting 
• 08:00-16:00: Infection in Pulmonary Vascular Disease (iPVD) Consortium Meeting 
• 08:00-12:00: Paediatric Task Force Meeting 
• 12:00-18:00: PAH-ICON: International Consortium for Genetic Studies in PAH Meeting 
• 16:00-18:00: High Altitude Task Force Meeting

Main Congress

• 30 January: Heterogeneity in the presentation of Pulmonary Hypertension (PH) 
• Session 1: Establishing the framework for the classification and diagnosis of PH worldwide 
• Session 2: Risk stratification and treatment in the new era of PH therapeutics 
• 31 January: Heterogeneity in the pathobiology of PH 
• Session 3: Vascular heterogeneity in chronic lung disease 
• Session 4: Heterogeneity in PH associated with heart disease 
• 1 February: Learning from heterogeneity to improve outcomes in PH 
• Session 5: The individual exposome and its contribution to PH heterogeneity 
• Session 6: Quantifying therapeutic responses 
• Session 7: Leveraging disease heterogeneity in clinical trial design

The Congress will include a welcome drinks reception, poster presentations and the opportunity to attend the following functions. All functions are free to attend, apart from the Gala Dinner, which is $60 per person. Please book onto the functions when you register for Congress.

• Women in PH Luncheon: Following our successful Luncheon in PVRI 2024 London, we are delighted to bring to you the Women in PH Luncheon at PVRI 2025 Rio. “Women in PH” began as a way to support educational opportunities for women in PH and strengthen their professional network, aimed at building an inclusive, diverse community. We strive to unite and amplify women’s voices to strengthen their collective interests. We look forward to another exhilarating event. We are very grateful to United Therapeutics Corporation for sponsoring this Luncheon.
• Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals: This new Career Catalyst Luncheon will offer micro-mentoring opportunities to early-career PH professionals and trainees. We’ll facilitate networking and connection-building between early-career PH professionals and provide opportunities to connect with renowned senior and mid-career PH researchers in a welcoming and informal setting. If you’re an early career colleague, we hope you’ll join us!
• Gala Dinner & Awards Evening: Join us for an evening of celebration at our Gala Dinner & Awards Evening, where excellence will be honoured and memories made. Together, we’ll celebrate the impact each member of our community makes with good food and wine, a DJ, and a Bossa Nova band.
• Hot topics from PVRI GoDeep, led by Werner Seeger: The session will include an overview of the GoDeep meta-registry, risk scores beyond group 1 PH – baseline and follow-up, PAH-targeted therapies non-PAH PH, the impact of gender and ethnicity on survival with PH, and positive therapy response as predictor for survival: hemodynamic response versus risk score improvement versus multicomponent clinical improvement.